Authors


Health Matters, University of California San Diego Television

Latest:

Health Matters: Safety of Childhood Vaccinations

Vaccines are one of the most important public health advances in the 20th century, yet fewer people are getting them.


Ellisiv B. Mathiesen, MD, PhD

Latest:

Elevated high-density lipoprotein cholesterol and carotid atherosclerosis

We assessed the relationship between high-density lipoprotein (HDL) cholesterol level and carotid plaque progression in 1952 men and women with preexisting carotid atherosclerosis over a period of 7 years. The HDL cholesterol level was inversely related to plaque growth. The plaques that became more echogenic during follow-up had a lower growth rate compared with those that became more echolucent. These findings suggest that HDL cholesterol stabilizes plaques and counteracts their growth by reducing their lipid content and inflammation.


Jacob Witkowski

Latest:

TechSectors - Medical Device: Teaching the Brain to Take the Right Step

Can the application of chaos theory lead to better clinical rehabilitation and assistive devices for patients suffering from neuromuscular disorders?


Susan B. Garavaglia, PhD, MBA

Latest:

Is There a Relationship between Early Statin Compliance and a Reduction in Healthcare Utilization?

Compliance with statin therapy in the first two years of use may reduce hospitalization rates and direct medical costs in the subsequent year.


Lisa Marie Bernardo, PhD, RN

Latest:

Meeting the Challenge of Daily Physical Activity

Nursing is a demanding profession, especially for oncology nurses who often deal with depressed, angry, and frightened patients.


Jean-Pierre Bassand, MD

Latest:

Renal dysfunction in older age groups and mortality after acute myocardial infarction

Only one third of patients admitted to the hospital with acute myocardial infarction have normal renal function, and 17% have severe renal impairment. Decreased renal function is associated with the presence of comorbid conditions, underuse of effective treatments, and higher mortality. Renal function parameters should not only be included in scoring systems to assess risk levels, but patients with abnormal renal function should benefit from careful application of guidelines-recommended treatments for acute and long-term care.


Steve Davis, MD, DFAPA

Latest:

AMIA 2010

Steve Davis, MD, DFAPA, shares his notes from the annual meeting of the American Medical Informatics Association.


Marie Crandall, MD, MPH

Latest:

Hydatid Liver Disease in a Patient with Chronic Right Upper-Quadrant Abdominal Pain

Hydatid disease of the liver is endemic in some areas of the world but is rarely encountered in the United States. The disease is usually caused by the parasite Echinococcus granulosus. Physicians who work within multicultural communities must be aware of this disease and its treatment. We present the case of a 35-year-old Mexican woman who complained of chronic right upper-quadrant pain. Computed tomography scanning revealed a ring-enhancing lesion within the right lobe of the liver, suggesting the diagnosis of a hydatid cyst. Following a course of antiparasitic therapy, the cyst was surgically removed. Six months later, the patient was pain free.


from the 1department of community and preventive medicine

Latest:

New Framingham Heart Study global cardiovascular risk instruments: Helping physicians optimize their patients' cardiovascular care

While most patients are concerned about their risk for myocardial infarction, it is important to remember that the risk factors for death from all cardiovascular diseases, including stroke, peripheral arterial disease, and coronary artery disease, are similar.


Mary Blanton Wheeler, PharmD, MPH

Latest:

A New Pulmonary Arterial Hypertension Drug on the Horizon

In pulmonary arterial hypertension patients, riociguat serves as a reasonable first-line alternative to PDE-5 inhibitors or in combination therapy with an endothelin antagonist or inhaled prostacyclin analogues.


David R. Grube, MD

Latest:

Ten Facts About Medical Aid in Dying

What a longtime family practitioner in a state that authorizes medical aid in dying has learned through his own experience of the controversial practice.


Keith C. Ferdinand, MD

Latest:

Treatment Decisions and its Relation to Patient Accessibility

Final thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.


Colleen O'Leary

Latest:

Nurses as Full Partners in Health Care

A recent article outlined the recommendations from the Institute of Medicine that included more training and independence for nurses.



Karl Isaaz, MD: From the Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France.

Latest:

Should radiofrequency ablation be first-line therapy after a first episode of symptomatic atrial flutter?

Radiofrequency catheter ablation (RFA) is a cost-effective approach that has modified the treatment of patients with supraventricular tachycardia. In the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) study, we compared RFA treatment with amiodarone therapy after the first episode of symptomatic atrial flutter. Results showed that RFA should be considered a first-line treatment, especially in elderly patients, because it has a better long-term success rate, the same risk of subsequent atrial fibrillation as amiodarone, and fewer secondary effects compared with amiodarone. Radiofrequency catheter ablation first-line therapy should be recommended in routine clinical practice, even when the atrial flutter is isolated without a previously documented atrial fibrillation episode.





Wayne Altman, MD

Latest:

Heartache Over New Cholesterol Treatment Guidelines

To produce the greatest impact from the implementation of the new American College of Cardiology and American Heart Association guidelines for the treatment of hypercholesterolemia in the primary prevention of cardiovascular disease (CVD), physicians should counsel patients on the benefits and risks of medication intervention to prevent CVD, but also explain the absolute necessity of regular exercise and abstention from tobacco use.


Dan Theodorescu, MD, PhD

Latest:

Can New Technologies Be Used to Predict Treatment Response in Cancer Patients?

The next leap forward in cancer treatment will see physicians tailoring treatments based on patients' individualized tumor profiles.





Kausik K. Ray, MD, MRCP: From the Department of Public Health

Latest:

Novel Research Frontiers on the Management of FCS

Panelists discuss how various new and developing approaches for treating familial chylomicronemia syndrome are emerging, and emphasize the importance for clinicians to integrate these advancements into practice while staying current with ongoing research and evolving treatment strategies.


Frederick A. Spencer, MD3: From the 1Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School,Worce

Latest:

Survival after heart failure

We conducted a multi-hospital population-based study of 2445 residents of a large New England metropolitan area hospitalized with acute heart failure and found that the long-term prognosis for these patients remains poor. More than one third of patients died in the first year after hospital discharge,and nearly 4 of 5 patients died over the 5-year follow-up period. Several demographic and clinical factors were associated with an adverse prognosis. It is important to know the factors that negatively affect long-term survival after hospital discharge for decompensated heart failure so that treatment can be directed toward specific high-risk groups.



Victor Dostrow

Latest:

New Antiepileptic Drugs: A Bit of Bad News

The new generation of AEDs is not perfect. Is anyone surprised by this?


Mark T. Kearney, MD: From the Leeds Institute of Genetics, Health

Latest:

Mortality of patients with diabetes mellitus and acute myocardial infarction

We evaluated trends in the treatment and mortality of patients with and without diabetes mellitus and acute myocardial infarction over the last decade. Despite improvements in the provision of evidence-based care, patients with diabetes did not derive improvements in long-term survival.



© 2024 MJH Life Sciences

All rights reserved.